Intra-Cellular Therapies, Inc. Annual Revenues in USD from 2012 to 2017

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Intra-Cellular Therapies, Inc. quarterly/annual Revenues history and growth rate from 2012 to 2017.
  • Intra-Cellular Therapies, Inc. Revenues for the quarter ending December 31, 2022 was $87.9M, a 242% increase year-over-year.
  • Intra-Cellular Therapies, Inc. Revenues for the twelve months ending December 31, 2022 was $250M, a 199% increase year-over-year.
  • Intra-Cellular Therapies, Inc. annual Revenues for 2017 was $246K, a 25.7% decline from 2016.
  • Intra-Cellular Therapies, Inc. annual Revenues for 2016 was $331K, a 262% increase from 2015.
  • Intra-Cellular Therapies, Inc. annual Revenues for 2015 was $91.4K, a 84.2% decline from 2014.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2017 $246K -$84.9K -25.7% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-01
2016 $331K +$239K +262% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 $91.4K -$486K -84.2% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $577K -$2.16M -78.9% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 $2.74M -$381K -12.2% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-25
2012 $3.12M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.